Dyne Therapeutics Inc
Research Dyne Therapeutics Inc (DYN) on Bullrun: market cap USD 3.51B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerDYN
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Market capUSD 3.51B
- Financial periodFY2025
- Net income-USD 446
- Free cash flow-USD 405.13M
Valuation Snapshot
latest market cap is USD 3.51B.
About Dyne Therapeutics Inc
Dyne Therapeutics, Inc., a clinical-stage neuromuscular disease company, focuses on discovering and developing therapeutics for neuromuscular diseases in the United States. The company is developing a portfolio of muscle disease therapeutics, including programs in myotonic dystrophy type 1; duchenne muscular dystrophy; facioscapulohumeral dystrophy; and Pompe disease, as well as rare skeletal muscle, and cardiac and metabolic muscle diseases using its FORCE platform that delivers disease-modifying therapeutics.
Frequently asked questions
What is Dyne Therapeutics Inc's market cap?
Dyne Therapeutics Inc's market capitalization is USD 3.51B.
What does Dyne Therapeutics Inc do?
Dyne Therapeutics, Inc., a clinical-stage neuromuscular disease company, focuses on discovering and developing therapeutics for neuromuscular diseases in the United States. The company is developing a portfolio of muscle disease therapeutics, including programs in myotonic dystrophy type 1;